Literature DB >> 8859908

Lack of Fos-like immunoreactivity after spontaneous seizures or reinduction of status epilepticus by pilocarpine in rats.

L E Mello1, C M Kohman, A M Tan, E A Cavalheiro, D M Finch.   

Abstract

Acute seizures and status epilepticus induced by pilocarpine lead to the expression of Fos-like immunoreactivity in several specific brain areas in a manner similar to that of other models of limbic seizures. Upon development of status epilepticus after systemic pilocarpine injection, animals develop a state where chronic spontaneous seizures recur. Assessment of Fos-like immunoreactivity after such spontaneous seizures or after status epilepticus reinduction reveals either lack of staining or a weak reaction in a few brain areas including the ventral tip of the dentate gyrus, prepiriform, lateral piriform and perirhinal cortices, and scattered locations throughout temporal neocortex. Our results suggest that status epilepticus induction may lead to a long-lasting state of Fos down-regulation.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8859908     DOI: 10.1016/0304-3940(96)12562-3

Source DB:  PubMed          Journal:  Neurosci Lett        ISSN: 0304-3940            Impact factor:   3.046


  10 in total

1.  Do seizures in the pilocarpine model start in the hippocampal formation?

Authors:  John G R Jefferys
Journal:  Epilepsy Curr       Date:  2014-07       Impact factor: 7.500

Review 2.  Defining "epileptogenesis" and identifying "antiepileptogenic targets" in animal models of acquired temporal lobe epilepsy is not as simple as it might seem.

Authors:  Robert S Sloviter; Argyle V Bumanglag
Journal:  Neuropharmacology       Date:  2012-02-04       Impact factor: 5.250

3.  Persistent increased DNA-binding and expression of serum response factor occur with epilepsy-associated long-term plasticity changes.

Authors:  T A Morris; N Jafari; A C Rice; O Vasconcelos; R J DeLorenzo
Journal:  J Neurosci       Date:  1999-10-01       Impact factor: 6.167

Review 4.  Neuroanatomical clues to altered neuronal activity in epilepsy: from ultrastructure to signaling pathways of dentate granule cells.

Authors:  Carolyn R Houser; Nianhui Zhang; Zechun Peng; Christine S Huang; Yliana Cetina
Journal:  Epilepsia       Date:  2012-06       Impact factor: 5.864

5.  Early activation of ventral hippocampus and subiculum during spontaneous seizures in a rat model of temporal lobe epilepsy.

Authors:  Izumi Toyoda; Mark R Bower; Fernando Leyva; Paul S Buckmaster
Journal:  J Neurosci       Date:  2013-07-03       Impact factor: 6.167

6.  Rapamycin suppresses mossy fiber sprouting but not seizure frequency in a mouse model of temporal lobe epilepsy.

Authors:  Paul S Buckmaster; Felicia H Lew
Journal:  J Neurosci       Date:  2011-02-09       Impact factor: 6.167

7.  Down-regulation of BK channel expression in the pilocarpine model of temporal lobe epilepsy.

Authors:  Luis F Pacheco Otalora; Eder F Hernandez; Massoud F Arshadmansab; Sebastian Francisco; Michael Willis; Boris Ermolinsky; Masoud Zarei; Hans-Guenther Knaus; Emilio R Garrido-Sanabria
Journal:  Brain Res       Date:  2008-01-18       Impact factor: 3.252

8.  The glucocorticoid receptor specific modulator CORT108297 reduces brain pathology following status epilepticus.

Authors:  Aynara C Wulsin; Kimberly L Kraus; Kevin D Gaitonde; Venkat Suru; Salwa R Arafa; Benjamin A Packard; James P Herman; Steve C Danzer
Journal:  Exp Neurol       Date:  2021-03-18       Impact factor: 5.620

9.  Effect of repeated seizures on spatial exploration and immediate early gene expression in the hippocampus and dentate gyrus.

Authors:  Alena Kalinina; Zakhar Krekhno; Janet Yee; Hugo Lehmann; Neil M Fournier
Journal:  IBRO Neurosci Rep       Date:  2021-12-31

10.  Resilience to audiogenic seizures is associated with p-ERK1/2 dephosphorylation in the subiculum of Fmr1 knockout mice.

Authors:  Giulia Curia; Fabio Gualtieri; Regina Bartolomeo; Riccardo Vezzali; Giuseppe Biagini
Journal:  Front Cell Neurosci       Date:  2013-04-25       Impact factor: 5.505

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.